Beijing Tong Ren Tang Chinese Medicine Co (BJTRF) Financial Statements
Beijing Tong Ren Tang Chinese Medicine Co Financial Overview
Beijing Tong Ren Tang Chinese Medicine Co's market cap is currently $602.82M. The company's EPS TTM is $0.55; its P/E ratio is 10.23; and it has a dividend yield of 7.32%. Beijing Tong Ren Tang Chinese Medicine Co has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.51B | $ 1.61B | $ 1.52B | $ 1.73B | $ 1.56B |
| Gross Profit | $ 925.58M | $ 1.07B | $ 1.05B | $ 1.15B | $ 1.12B |
| Operating Income | $ 472.24M | $ 576.92M | $ 624.15M | $ 811.58M | $ 778.46M |
| EBITDA | $ 574.36M | $ 722.32M | $ 779.54M | $ 907.63M | $ 852.81M |
| Net Income | $ 397.22M | $ 500.28M | $ 540.39M | $ 645.88M | $ 607.84M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.28B | $ 1.82B | $ 2.38B | $ 2.24B | $ 2.28B |
| Total Assets | $ 4.66B | $ 4.56B | $ 4.43B | $ 4.23B | $ 3.83B |
| Total Debt | $ 126.54M | $ 123.42M | $ 131.81M | $ 103.08M | $ 128.48M |
| Net Debt | $ -2.10B | $ -1.65B | $ -868.00M | $ -1.89B | $ -1.53B |
| Total Liabilities | $ 291.88M | $ 313.09M | $ 413.75M | $ 486.49M | $ 295.48M |
| Stockholders' Equity | $ 4.19B | $ 4.08B | $ 3.87B | $ 3.60B | $ 3.42B |
| Cash Flow | |||||
| Free Cash Flow | $ 827.05M | $ -260.42M | $ 438.96M | $ 508.94M | $ 753.74M |
| Operating Cash Flow | $ 868.23M | $ -217.25M | $ 460.83M | $ 547.44M | $ 777.17M |
| Investing Cash Flow | $ -37.73M | $ 1.35B | $ -1.08B | $ 335.41M | $ -265.73M |
| Financing Cash Flow | $ -381.05M | $ -355.30M | $ -372.18M | $ -535.42M | $ -278.65M |
Currency in HKD